Literature DB >> 17471287

Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

T Hashimoto1, D Arion, T Unger, J G Maldonado-Avilés, H M Morris, D W Volk, K Mirnics, D A Lewis.   

Abstract

In subjects with schizophrenia, impairments in working memory are associated with dysfunction of the dorsolateral prefrontal cortex (DLPFC). This dysfunction appears to be due, at least in part, to abnormalities in gamma-aminobutyric acid (GABA)-mediated inhibitory circuitry. To test the hypothesis that altered GABA-mediated circuitry in the DLPFC of subjects with schizophrenia reflects expression changes of genes that encode selective presynaptic and postsynaptic components of GABA neurotransmission, we conducted a systematic expression analysis of GABA-related transcripts in the DLPFC of 14 pairs of schizophrenia and age-, sex- and post-mortem interval-matched control subjects using a customized DNA microarray with enhanced sensitivity and specificity. Subjects with schizophrenia exhibited expression deficits in GABA-related transcripts encoding (1) presynaptic regulators of GABA neurotransmission (67 kDa isoform of glutamic acid decarboxylase (GAD(67)) and GABA transporter 1), (2) neuropeptides (somatostatin (SST), neuropeptide Y (NPY) and cholecystokinin (CCK)) and (3) GABA(A) receptor subunits (alpha1, alpha4, beta3, gamma2 and delta). Real-time qPCR and/or in situ hybridization confirmed the deficits for six representative transcripts tested in the same pairs and in an extended cohort, respectively. In contrast, GAD(67), SST and alpha1 subunit mRNA levels, as assessed by in situ hybridization, were not altered in the DLPFC of monkeys chronically exposed to antipsychotic medications. These findings suggest that schizophrenia is associated with alterations in inhibitory inputs from SST/NPY-containing and CCK-containing subpopulations of GABA neurons and in the signaling via certain GABA(A) receptors that mediate synaptic (phasic) or extrasynaptic (tonic) inhibition. In concert with previous findings, these data suggest that working memory dysfunction in schizophrenia is mediated by altered GABA neurotransmission in certain DLPFC microcircuits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471287      PMCID: PMC2882638          DOI: 10.1038/sj.mp.4002011

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  70 in total

1.  Statistical analysis of MPSS measurements: application to the study of LPS-activated macrophage gene expression.

Authors:  G A Stolovitzky; A Kundaje; G A Held; K H Duggar; C D Haudenschild; D Zhou; T J Vasicek; K D Smith; A Aderem; J C Roach
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

2.  Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors.

Authors:  Patrick S Mangan; Chengsan Sun; Mackenzie Carpenter; Howard P Goodkin; Werner Sieghart; Jaideep Kapur
Journal:  Mol Pharmacol       Date:  2004-12-21       Impact factor: 4.436

3.  Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics.

Authors:  J S Lund; D A Lewis
Journal:  J Comp Neurol       Date:  1993-02-08       Impact factor: 3.215

4.  GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.

Authors:  D Volk; M Austin; J Pierri; A Sampson; D Lewis
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

Review 5.  Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors.

Authors:  Mark Farrant; Zoltan Nusser
Journal:  Nat Rev Neurosci       Date:  2005-03       Impact factor: 34.870

6.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.

Authors:  A Guidotti; J Auta; J M Davis; V Di-Giorgi-Gerevini; Y Dwivedi; D R Grayson; F Impagnatiello; G Pandey; C Pesold; R Sharma; D Uzunov; E Costa; V DiGiorgi Gerevini
Journal:  Arch Gen Psychiatry       Date:  2000-11

7.  Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.

Authors:  K Mirnics; F A Middleton; A Marquez; D A Lewis; P Levitt
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

8.  Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.

Authors:  E Fuller Torrey; Beata M Barci; Maree J Webster; John J Bartko; James H Meador-Woodruff; Michael B Knable
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

9.  Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.

Authors:  Takanori Hashimoto; Sarah E Bergen; Quyen L Nguyen; Baoji Xu; Lisa M Monteggia; Joseph N Pierri; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

10.  Platform influence on DNA microarray data in postmortem brain research.

Authors:  Deborah Hollingshead; David A Lewis; Károly Mirnics
Journal:  Neurobiol Dis       Date:  2005-04       Impact factor: 5.996

View more
  248 in total

1.  Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

Authors:  Allison A Curley; Dominique Arion; David W Volk; Josephine K Asafu-Adjei; Allan R Sampson; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

2.  Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia.

Authors:  James M Gold; Britta Hahn; Wei Wei Zhang; Benjamin M Robinson; Emily S Kappenman; Valerie M Beck; Steven J Luck
Journal:  Arch Gen Psychiatry       Date:  2010-06

Review 3.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

4.  Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region.

Authors:  Alice Y Wang; Kathryn M Lohmann; C Kevin Yang; Eric I Zimmerman; Harry Pantazopoulos; Nicole Herring; Sabina Berretta; Stephan Heckers; Christine Konradi
Journal:  Acta Neuropathol       Date:  2011-10-04       Impact factor: 17.088

5.  Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.

Authors:  Monica Beneyto; Andrew Abbott; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2010-09-15       Impact factor: 5.357

6.  Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain.

Authors:  Elizabeth Spiteri; Genevieve Konopka; Giovanni Coppola; Jamee Bomar; Michael Oldham; Jing Ou; Sonja C Vernes; Simon E Fisher; Bing Ren; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

7.  Modulation of behavioral networks by selective interneuronal inactivation.

Authors:  M J Schmidt; S Horvath; P Ebert; J L Norris; E H Seeley; J Brown; L Gellert; M Everheart; K A Garbett; T W Grice; R M Caprioli; K Mirnics
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

Review 8.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

10.  Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons.

Authors:  Gregory B Bissonette; Mihyun H Bae; Tejas Suresh; David E Jaffe; Elizabeth M Powell
Journal:  Behav Brain Res       Date:  2013-11-07       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.